Taken together, our data show that GPRC5B helps to maintain a mature β cell phenotype by regulating the cAMP/CREB/MafA pathway and that genetic inactivation of this receptor leads to reduced insulin secretion and glucose intolerance in HFD-fed mice. This evidence concerns the gene CREB1 and Glucose intolerance.